SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

SUVEN LIFE SCIENCES

BSE: 530239 29 Sep 2025
Healthcare
₹ 225.4
Suven Life Sciences Ltd. specializes in Healthcare Research- Analytics & Technology within the Healthcare sector.

SUVEN LIFE SCIENCES - Share Price & Details

Market Cap
₹5,147
High /Low
272.0 / 95.2
Stock P/E
NA
Book Value
₹36.7
Dividend Yield
0.0
ROCE
-5.72
ROE
₹-5.72
Face Value
1.0
PEG Ratio
NA
EVEBITDA
₹-124.0
Debt
0.00
CMP / FCF
-120.0
Debt to equity
₹0.0
NP Ann
-47.1
High price all time
272.0
Piotroski score
₹2.0
Graham Number
NA
No. Eq. Shares
21.8
Net CF
₹-3.94
Net profit
-47.1
Price to book value
6.44
Interest Coverage
₹-941.0
Low price all time
0.59
Industry PE
45.1
Reserves
₹778
Free Cash Flow
₹-84.7

Broker Recommendations

No broker recommendations available

We couldn’t find any recent recommendations for this company (matched by symbol or BSE code). Please check back later.


Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
FABINO ENTERPRISES LIMITEDNANANANA5.0984.8
Triochem Products Ltd.,NANANANA0
SUVEN LIFE SCIENCES LTD.24.56-147.7918.67-0.685,147
SEQUENT SCIENTIFIC LTD.525.533.7410.70.134770158.0
Dishman Carbogen Amcis Limited1002.826.7628.60.17441037.1

Peer Comparison Chart


About SUVEN LIFE SCIENCES

Suven Life Sciences Ltd., with Security Code 530239, is a leading player in the Healthcare Research- Analytics & Technology industry, categorized under the Healthcare sector, offering Equity instruments.


Order Book


Latest News

Should You Watch Suven Life Sciences Limited for Sector Rotation Upside - Economic Indicators Overview & Minimal Capital Growth Ideas

(28 Sep 2025)
【Stock Buzz】✌️ Expert predictions on high-growth stocks, supported by real-time market data and trends to help you make the best investment...
Read more →

Sai Life Sciences shares fall 4% as TPG eyes ₹2,500 cr stake sale via block deals

(26 Aug 2025)
Global private equity major TPG Capital plans to offload its entire 14.72% stake in Sai Life Sciences, valued at around ₹2500 crore,...
Read more →

Cohance Lifesciences announces $10 million investment in US-based arm

(16 Aug 2025)
Cohance Lifesciences is investing USD 10 million to expand bioconjugation capabilities at its US subsidiary, NJ Bio, enhancing its ADC...
Read more →

Suven Life Sciences Limited (SUVEN) Quarterly Results Are Out - Capitalize on market opportunities with confidence

(03 Aug 2025)
Suven Life Sciences Limited (SUVEN) Quarterly Results Are Out ✌️【Investor Sentiment】✌️ We specialize in spotting breakout trends early...
Read more →

Where Could Suven Life Sciences Limited (530239) Be Headed - Exponential return rates

(25 Jul 2025)
Where Could Suven Life Sciences Limited (530239) Be Headed ✌️【Stock Buzz】✌️ Our 200%+ gainers are no accident — they're the product of deep...
Read more →

Suven Life Sciences Limited (530239) Sees Unusual Trading Volume - Unprecedented profits

(25 Jul 2025)
Suven Life Sciences Limited (530239) Sees Unusual Trading Volume ✌️【Trading Ideas】✌️ Take control of your investments with real-time stock...
Read more →